<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prevalence of a <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> was assessed by simultaneously performing transesophageal contrast echocardiography and transcranial contrast Doppler sonography (TCD) in 137 subjects (mean age 36 years) with <z:hpo ids='HP_0001297'>stroke</z:hpo> of unclarified etiology (n = 41), clarified etiology (n = 33), and in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (n = 63; mean age 32 years) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001655'>Patent foramen ovale</z:hpo> was found significantly more often in patients with unclarified than clarified <z:hpo ids='HP_0001297'>strokes</z:hpo> or in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (66% vs 33%, or 43%) </plain></SENT>
<SENT sid="2" pm="."><plain>Massive <z:e sem="disease" ids="C0238096" disease_type="Disease or Syndrome" abbrv="">paradoxical embolism</z:e> through a <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo>, identified by TCD, occurred significantly (p &lt; 0.01) more often in patients with unclarified (64%) than clarified (27%) <z:hpo ids='HP_0001297'>strokes</z:hpo> or in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (3%) </plain></SENT>
<SENT sid="3" pm="."><plain>However, minimal shunts were typical in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (79%) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001655'>Patent foramen ovale</z:hpo> was detected indirectly by TCD when calculated on the basis of transesophageal contrast echocardiographic findings (sensitivity 89%, specificity 92%) </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, TCD reliably detects paradoxical <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> through a <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo>, and provides important additional information for evaluating its clinical relevance by semi-quantification of embolic contrast material </plain></SENT>
</text></document>